International Benchmarking of US Immunology Research (1999) / Chapter Skim
Currently Skimming:
5. Summary and Conclusions
5. Summary and Conclusions
Pages 51-54
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 51... ...
That is not a surprising result, given the size of the US enterprise, which writes some 60% of the immunology papers published each year. However, what is of greater interest, given the size of the enter se, is that in some sub-subfields the United States is only among the world leaders: lymphocyte development and self-nonself recognition, inherited immunodeficiency, tumor immunology, and transplantation and immunosuppressive drugs.
|
From page 52... ...
(critically, it is the individual invest~gator-rather than the department chair or other research colleagues, as it open is in many European countr~es-that has the authority and autonomy to pursue a specific research interest. Unlike many foreign countries, the United States supports research institutions and medical schools through state governments and private foundations, and this allows the Deedom and flexibility to develop innovative research programs.
|
From page 53... ...
That raises the possibility that foreign students wall elect to seek training and jobs in their own respective countries. The loss of talented students in immunology, both domestic and international, would have profound implications for the ability of the United States to maintain its leadership role.
|
From page 54... ...
54 International Benchmarking of US Immunology Research
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.